In 2023, the mortality rate for female breast malignant neoplasms in Japan stood at approximately 24.2 deaths per hundred thousand women. From 2024 onwards, forecasted data indicates a gradual increase, rising from 24.5 in 2024 to 26.0 by 2028. This suggests a year-on-year growth of around 1.6% to 1.7%, highlighting a consistent upward trend. Over the five-year forecast horizon, the compound annual growth rate (CAGR) is approximately 1.5%.
Future trends to watch include advancements in early detection and treatment technologies, public health initiatives focused on prevention, and changes in healthcare policies that could curtail this rising trend.
